BrandonMatthewHayes-LattinMD
Hematology • Portland, ORHematologic Oncology
Professor of Medicine, Medical Director of Hematology and Medical Oncology
Dr. Hayes-Lattin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
# L586
Portland, OR 97239Phone+1 503-494-8534Fax+1 503-494-3257
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2001 - 2004- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
University of Washington School of MedicineClass of 1997, MD
StanfordBS, 1988 - 1992
Certifications & Licensure
WA State Medical License 2005 - 2026
OR State Medical License 1998 - 2025
American Board of Internal Medicine Hematology
Clinical Trials
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
- Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy Start of enrollment: 2005 Jan 01
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.Somya Khare, Staci Williamson, Brittany O'Barr, Levanto Schachter, Andy Chen
Clinical Lymphoma, Myeloma & Leukemia. 2025-02-01 - Multisystem ALK-Positive Histiocytosis With DCTN1::ALK Fusion in an Adult, Responsive to Alectinib: Case Report and Literature Review.Gregory S Phillips, Maxwell Knapp, Keith C Olsen, William Martin, Brandon Hayes-Lattin
Journal of Cutaneous Pathology. 2025-01-01 - 1 citationsThromboprophylaxis with intermediate dose enoxaparin during asparaginase containing induction for young adults with acute lymphoblastic leukemia.Hong De Sa, Thomas Deloughery, Andy Kaempf, Curtis Lachowiez, Jessica Leonard
Leukemia & Lymphoma. 2025-01-01
Press Mentions
Raising Awareness of the Financial Impact of Cancer on Young Adult SurvivorsJuly 10th, 2018
How to Help Young Patients Preserve Their FertilityAugust 10th, 2017
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
